Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Hyperthermia × Gemcitabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 63 Carcinoma, Non-Small-Cell Lung 39 Lung Neoplasms 22 Nasopharyngeal Carcinoma 21 Breast Neoplasms 13 Lymphoma, Large B-Cell, Diffuse 12 Neoplasm Metastasis 11 Cholangiocarcinoma 11 Ovarian Neoplasms 9 Recurrence 8 Lymphoma, Extranodal NK-T-Cell 8 Biliary Tract Neoplasms 8 Urinary Bladder Neoplasms 6 Triple Negative Breast Neoplasms 6 Lymphoma 6 Neoplasms 5 Nasopharyngeal Neoplasms 5 Lymphoma, T-Cell, Peripheral 5 Uterine Cervical Neoplasms 4 Unspecified Adult Solid Tumor, Protocol Specific 4 Hodgkin Disease 4 Head and Neck Neoplasms 4 Gallbladder Neoplasms 4 Carcinoma, Transitional Cell 4 Adenocarcinoma of Lung 4 Stomach Neoplasms 3 Rectal Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, T-Cell 3 Lymphoma, Non-Hodgkin 3

Interventions

Diathermy 6 Radiotherapy 2 Radiation 2 Drug Therapy 2 Cisplatin 2 Radiation Dose Hypofractionation 1 Mitomycin 1 Immune Checkpoint Inhibitors 1 Gemcitabine 1 Fluorouracil 1 Doxorubicin 1 Docetaxel 1 Cyclophosphamide 1 Chemoradiotherapy 1 Capecitabine 1 Brachytherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01077427 2017-11-17

HEAT

Klinikum der Universitaet Muenchen, Grosshadern

Phase 3 Unknown

Gastrointestinal

Hyperthermia, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡